A collection of TBL summaries relevant to Intensive Care Medicine

MERCURI-2 – Dapagliflozin and AKI Post Cardiac Surgery

Dapagliflozin and Acute Kidney Injury Following Cardiac Surgery A Randomized Clinical Trial Oosterom-Eijmael et al. JAMA. 2026;336(9):765-773. doi:10.1001/jama.2026.9268 Clinical Question In adults undergoing elective cardiac surgery, does peri-operative dapagliflozin, initiated the day before surgery, compared with placebo, reduce acute kidney injury (AKI) within 7 post-operative days? Background AKI occurs in up to 50% of patients undergoing cardiac surgery and is […]

Continue reading »

Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury

Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury Gaudry. NEJM 2026. DOI: 10.1056/NEJMoa2608397 Clinical Question Among critically ill patients with AKI who had indications for RRT, is the use of intermittent haemodialysis (IHD) non-inferior to continuous renal replacement therapy (CRRT) with respect to major adverse kidney events by day 90 (MAKE90)? Background AKI is associated with increased short-term mortality; […]

Continue reading »

LOGICAL – Conservative Oxygen after Cardiac Arrest

Conservative Oxygen for Unresponsive Patients after Cardiac Arrest The LOGICAL Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group. NEJM. 2026. doi: 10.1056/NEJMoa2513814 Clinical Question In patients who are unresponsive after cardiac arrest, does limiting oxygen exposure to achieve acceptable oxygenation increase the likelihood of surviving with a favourable functional outcome Background Brain damage and unfavourable […]

Continue reading »

Sodium Bicarbonate for Metabolic Acidosis in the Intensive Care Unit (SODa-BIC) trial

Sodium Bicarbonate for Metabolic Acidosis in the Intensive Care Unit (SODa-BIC) trial The SODa-BIC Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group. NEJM 2026; doi: 10.1056/NEJMoa2600526 Clinical Question In critically ill adults with metabolic acidosis (pH < 7.30) receiving vasopressors, does sodium bicarbonate decrease the risk of major adverse kidney events within 30 days compared […]

Continue reading »

TOP: Liberal or restrictive post-op transfusion

Liberal or Restrictive Postoperative Transfusion in Patients at High Cardiac Risk: The TOP Randomized Clinical Trial Kougias P. JAMA 2025;334:2197-2207. doi:10.1001/jama.2025.20841 Clinical Question In high cardiac risk adults who develop postoperative anaemia following vascular or general surgery, does a liberal transfusion threshold (Hb <10 g/dL) compared to a restrictive transfusion threshold (Hb <7 g/dL) reduce 90‑day incidence of all‑cause death, […]

Continue reading »

LIBERATE-D – Conservative Dialysis Strategy

LIBERATE-D – A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury: The Liberation From Acute Dialysis (LIBERATE-D) Randomized Clinical Trial Liu KD, Siew ED, Tuot DS, Vijayan A, Umemoto GM, Birkelo BC, et al.  JAMA. 2026;335(4):326–335. doi:10.1001/jama.2025.21530 Clinical Question In clinically stable adults with AKI-D receiving IHD and expected to require outpatient dialysis after discharge, does […]

Continue reading »

BigPAK-2 – preventive care strategy to reduce acute kidney injury after major surgery

A preventive care strategy to reduce moderate or severe acute kidney injury after major surgery (BigpAK-2); a multinational, randomised clinical trial Zarbock. The Lancet 2025. doi: 10.1016/S0140-6736(25)01717-9 Clinical Question In patients at high risk of AKI undergoing major surgery, does a preventative care strategy based on KDIGO guidelines, compared to standard care lead to a reduction in moderate/severe AKI within […]

Continue reading »

ACTiVE – Automated Closed-Loop Ventilation vs Protocolized Conventional Ventilation

Effect of Automated Closed-Loop Ventilation vs Protocolized Conventional Ventilation on Ventilator-Free Days in Critically Ill Adults: A Randomized Clinical Trial Sinnige J. JAMA 2025. doi:10.1001/jama.2025.24384 Clinical Question Among critically ill mechanically ventilated adults, does early use of an automated closed-loop ventilation system (INTELLiVENT-ASV) increase ventilator-free days at day 28 (VFD-28) compared with protocolled conventional ventilation (CV)? Background Mechanical ventilation carries […]

Continue reading »

VENT-AVOID – Extracorporeal Carbon Dioxide Removal to Avoid Invasive Ventilation During COPD Exacerbations

Extracorporeal Carbon Dioxide Removal to Avoid Invasive Ventilation During Exacerbations of Chronic Obstructive Pulmonary Disease: VENT-AVOID Trial – A Randomized Clinical Trial Duggal et al. 2024; American Journal of Respiratory and Critical Care Medicine March 1, 2024 Pages xv-616 Clinical Question In patients with acute exacerbations of COPD who are either failing noninvasive ventilation (NIV) or failing to wean from […]

Continue reading »
1 2 3 … 45